Trevi Therapeutics, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Trevi Therapeutics, Inc. (TRVI) had Common Stock, Capital Shares Reserved for Future Issuance of 31.86 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-06
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 31.86M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 32.25M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 29.51M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 29.66M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2026-06-30 | 31.86M shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 32.25M shares 10-Q · filed 2026-05-05 | |
| 2025-12-31 | 29.51M shares 10-Q · filed 2026-08-06 | |
| 2025-09-30 | 29.66M shares 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 36.42M shares 10-Q · filed 2025-08-07 | |
| 2025-03-31 | 38.03M shares 10-Q · filed 2025-05-08 | |
| 2024-12-31 | 41.89M shares 10-K · filed 2026-03-17 | |
| 2024-09-30 | 47.24M shares 10-Q · filed 2024-11-06 | |
| 2024-06-30 | 48.50M shares 10-Q · filed 2024-08-08 | |
| 2024-03-31 | 50.65M shares 10-Q · filed 2024-05-07 | |
| 2023-12-31 | 49.22M shares 10-K · filed 2025-03-18 | |
| 2023-09-30 | 53.66M shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 83.66M shares 10-Q · filed 2023-08-10 | |
| 2023-03-31 | 86.70M shares 10-Q · filed 2023-05-11 | |
| 2022-12-31 | 84.19M shares 10-K · filed 2024-03-20 | |
| 2022-09-30 | 84.21M shares 10-Q · filed 2022-11-10 | |
| 2022-06-30 | 74.31M shares 10-Q · filed 2022-08-11 | |
| 2022-03-31 | 54.26M shares 10-Q · filed 2022-05-12 | |
| 2021-12-31 | 55.14M shares 10-K · filed 2023-03-16 | |
| 2021-09-30 | 4.56M shares 10-Q · filed 2021-11-10 | |
| 2021-06-30 | 4.56M shares 10-Q · filed 2021-08-12 | |
| 2021-03-31 | 4.57M shares 10-Q · filed 2021-05-13 | |
| 2020-12-31 | 3.65M shares 10-K · filed 2022-03-17 | |
| 2020-09-30 | 3.67M shares 10-Q · filed 2020-11-12 | |
| 2020-06-30 | 3.67M shares 10-Q · filed 2020-08-13 | |
| 2020-03-31 | 3.67M shares 10-Q · filed 2020-05-07 | |
| 2019-12-31 | 2.78M shares 10-K · filed 2021-03-25 | |
| 2019-09-30 | 2.78M shares 10-Q · filed 2019-11-14 | |
| 2019-06-30 | 2.78M shares 10-Q · filed 2019-08-12 | |
| 2019-03-31 | 10.33M shares 10-Q · filed 2019-06-14 | |
| 2018-12-31 | 10.69M shares 10-K · filed 2020-03-16 | 9.48M shares 10-Q · filed 2019-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |